Neptune Technologies & Bioressources Inc. - NTB.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neptune Technologies & Bioressources Inc. - NTB.V

NEPT 0.200

-45.9%

Mar 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The Ox who wrote (230)	5/30/2014 10:58:42 AM
From: Sultan	Read Replies (1) of 902

I was expecting this but the scale of claims are ridiculous.. Neptune Technologies Says Former CEO Seeks $8.5 Mln Cash and Shares For Constructive Dismissal: Shares Gain on Slim Pre-Bell Volume2 hours ago08:30 AM EDT, 05/30/2014 (MT Newswires) -- Neptune Technologies & Bioressources Inc. (NEPT, NTB.TO) said former president and CEO Henri Harland has filed a lawsuit against the company and its subsidiaries, claiming $8.5 million in damages for constructive dismissal. Harland resigned from his post as CEO of Neptune and its Acasti Pharma (ACST) and NeuroBiosciences units on on April 28, 2014. Harland is also seeking 500,000 new shares of each of Neptune, Acasti Pharma and NeuroBio as well as two blocks of 1,000,000 call options each on the shares held by Neptune in Acasti and NeuroBio. Neptune said the claim, as formulated, is without merit or cause and said it will vigorously defend the lawsuit. Harland has been requested to resign as director. The companies appointed Andre Godin as interim CEO on May 23rd. Neptune stock is up 3.6% pre-market in light trade at $2.55, while Acasti is unchanged.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next